The metabolic role of retinol binding protein 4: An update

Hormone and Metabolic Research

Volumn 44, Issue 1, 2012, Pages 6-14

  Christou, G A ^a   Tselepis, A D ^b   Kiortsis, D N ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

adipokines; adipose tissue; atherosclerosis; insulin resistance; lipid metabolism; metabolic syndrome

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ADIPONECTIN; COLESTYRAMINE; EXENDIN 4; EZETIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; MESSENGER RNA; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PROTEIN KINASE B; PYRUVATE KINASE; RECOMBINANT LEPTIN; RETINOL BINDING PROTEIN 4; RIMONABANT; ROSIGLITAZONE; SIBUTRAMINE; SULFONYLUREA; TETRAHYDROLIPSTATIN;

ABDOMINAL OBESITY; ABDOMINAL SUBCUTANEOUS FAT; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; BODY MASS; CALORIC RESTRICTION; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; DIET; DOWN REGULATION; ENERGY BALANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; GASTRIC BANDING; GLUCONEOGENESIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LIPOPROTEIN METABOLISM; LIVER CELL; LIVER FAILURE; LOW CALORY DIET; MEDITERRANEAN DIET; METABOLIC SYNDROME X; METABOLISM; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PARACRINE SIGNALING; PERIPHERAL VASCULAR DISEASE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESISTANCE TRAINING; REVIEW; RISK FACTOR; STOMACH BYPASS; STREPTOZOCIN DIABETES; STROKE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WESTERN BLOTTING;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RETINOL-BINDING PROTEINS;

EID: 84855256757     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1295491     Document Type: Review

References (108)

1. Blaner W S. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev: 1989; 10 308 316 (Pubitemid 19223063)
2. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman D S, Blaner W S. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem: 1992; 267 1805 1810
3. Yang Q, Graham T E, Mody N, Preitner F, Peroni O D, Zabolotny J M, Kotani K, Quadro L, Kahn B B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature: 2005; 436 356 362 (Pubitemid 41065039)
4. Cabre A, Lazaro I, Girona J, Manzanares A F, Plana N, Heras M, Masana L. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease. J Intern Med: 2007; 262 496 503 (Pubitemid 47404369)
5. Cho Y M, Youn B S, Lee H, Lee N, Min S S, Kwak S H, Lee H K, Park K S. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care: 2006; 29 2457 2461 (Pubitemid 44912252)
6. Graham T E, Yang Q, Bluher M, Hammarstedt A, Ciaraldi T P, Henry R R, Wason C J, Oberbach A, Jansson P, Smith U, Kahn B B. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects. N Engl J Med: 2006; 354 2552 2563 (Pubitemid 43882351)
7. Kloting N, Graham T E, Berndt J, Kralisch S, Kovacs P, Wason C J, Fasshauer M, Schon M R, Stumvoll M, Bluher M, Kahn B B. Serum Retinol-Binding Protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab: 2007; 6 79 87 (Pubitemid 46995778)
8. Kemp S F, Frindik J P. Effect of metabolic control on serum protein concentrations in diabetes. Acta Paediatr Scand: 1991; 80 938 943
9. Basu T K, Tze W J, Leichter J. Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr: 1989; 50 329 331 (Pubitemid 19208751)
10. Jourdan M, Jaleel A, Karakelides H, Ford G C, Kahn B B, Nair K S. Impact of type 1 diabetes and insulin treatment on plasma levels and fractional synthesis rate of retinol-binding protein 4. J Clin Endocrinol Metab: 2009; 94 5125 5130
11. Krill D, OLeary L, Koehler A N, Kramer M K, Warty V, Wagner M A, Dorman J S. Association of retinol binding protein in multiple-case families with insulin-dependent diabetes. Hum Biol: 1997; 69 89 96 (Pubitemid 27103373)
12. Chan T F, Chen H S, Chen Y C, Lee C H, Chou F H, Chen I J, Chen S Y, Jong S B, Tsai E M. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci: 2007; 14 169 174
13. Su Y, Hong J, Yan Q, Xu C, Gu W, Zhang Y, Shen C, Chi Z, Dai M, Xu M, Zhang Y, Liu Q, Wang W Q, Li X Y, Ning G. Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus. Diabetes Metab: 2010; 36 470 475
14. Stefan N, Hennige A M, Staiger H, Machann J, Shick F, Schleicher E, Fritsche A, Haring H U. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care: 2007; 30 1173 1178 (Pubitemid 46684644)
15. Gavi S, Stuart L M, Kelly P, Melendez M M, Mynarcik D C, Gelato M S, McNurlan M A. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab: 2007; 92 1886 1890 (Pubitemid 46997205)
16. Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes: 2009; 58 54 60
17. DeFronzo R A, Gunnarsson R, Bjrkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest: 1985; 76 149 155 (Pubitemid 15240430)
18. Abel E D, Peroni O, Kim J K, Kim Y B, Boss O, Hadro E, Minnemann T, Shulman G I, Kahn B B. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature: 2001; 409 6821 729 733 (Pubitemid 32144519)
19. Ost A, Danielsson A, Lidn M, Eriksson U, Nystrom F H, Strlfors P. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J: 2007; 21 3696 3704 (Pubitemid 350075157)
20. Stenkula K G, Said L, Karlsson M, Thorn H, Kjlhede P, Gustavsson J, Sderstrm M, Strlfors P, Nystrom F H. Expression of a mutant IRS inhibits metabolic and mitogenic signalling of insulin in human adipocytes. Mol Cell Endocrinol: 2004; 221 1 8 (Pubitemid 38829718)
21. Janke J, Engeli S, Boschmann M, Adams F, Bhnke J, Luft F C, Sharma A M, Jordan J. Retinol-binding protein 4 in human obesity. Diabetes: 2006; 55 2805 2810 (Pubitemid 44923680)
22. Yao-Borengasser A, Varma V, Bodles A M, Rasouli N, Phanavanh B, Lee M J, Starks T, Kern L M, Spencer H J 3rd, Rashidi A A, McGehee R E Jr, Fried S K, Kern P A. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab: 2007; 92 2590 2597 (Pubitemid 47037362)
23. Zeyda M, Stulnig T M. Obesity inflamation and insulin resistance A mini-review. Gerontology: 2009; 55 379 386
24. Balagopal P, Graham T E, Kahn B B, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab: 2007; 92 1971 1974 (Pubitemid 46997219)
25. Fleck A. Clinical and nutritional aspects of changes in acute-phase proteins during inflammation. Proc Nutr Soc: 1989; 48 347 354
26. Zobali F, Avci A, Canbolat O, Karasu C. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment. Cell Biochem Funct: 2002; 20 75 80
27. Kos K, Wong S, Tan B K, Kerrigan D, Randeva H S, Pinkney J H, Wilding J P. Human RBP4 adipose tissue expression is gender specific and influenced by leptin. Clin Endocrinol (Oxf): 2011; 74 197 205
28. Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K. Association of serum retinol binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab: 2007; 92 3224 3229 (Pubitemid 47236396)
29. Tetsuya T, Takeshi O, Kengo M, Masako Z, Kunichi K, Yushi H, Hideaki K, Masahiko F, Kazuro S, Masato K. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Metabolism: 2007; 56 1418 1424
30. Lin K D, Chang Y H, Wang C L, Yang Y H, Hsiao P J, Li T H, Shin S J. Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea. Transl Res: 2008; 151 309 314
31. Pftzner A, Schndorf T, Hanefeld M, Lbben G, Kann P H, Karagiannis E, Wilhelm B, Forst T. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients. Horm Metab Res: 2009; 41 202 206
32. You S H, Kim B S, Hong S J, Ahn C M, Lim D S. The effects of pioglitazone in reducing atherosclerosis progression and neointima volume in type 2 diabetic patients: prospective randomized study with volumetric intravascular ultrasonography analysis. Korean Circ J: 2010; 40 625 631
33. Derosa G, Maffioli P, Salvadeo S A, Ferrari I, Ragonesi P D, Quersi F, Franzetti I G, Gadaleta G, Ciccarelli L, Piccinni M N, DAngelo A, Cicero A F. Exenatide versus glibenclamide in patients with diabetes. Diabetes Technol Ther: 2010; 12 233 240
34. Derosa G, Maffioli P, DAngelo A, Fogari E, Bianchi L, Cicero A F. Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. J Diabetes Complications: 2011; 25 258 266
35. Haider D G, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab: 2007; 92 1168 1171 (Pubitemid 46465698)
36. Ingelsson E, Sundstrom J, Melhus H, Michaelsson K, Berne C, Vasan R S, Riserus U, Blomhoff R, Lind L, Arnlov J. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis: 2009; 206 38 39
37. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu F B, Franco O H, Wang J, Li H, Liu Y, Lin X. Elevated Retinol-binding protein 4 levels are associated with Metabolic Syndrome in Chinese people. J Clin Endocrinol Metab: 2007; 92 4827 4834 (Pubitemid 350223466)
38. Lee D C, Lee J W, Im J A. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism: 2007; 56 327 331
39. Lee J W, Lee H R, Shim J Y, Im J A, Lee D C. Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. Endocr J: 2008; 55 811 818
40. Lee J W, Im J A, Lee H R, Shim J Y, Youn B S, Lee D C. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obesity (Silver Spring): 2007; 15 2225 2232
41. Silha J V, Nyommba BL G, Leslie W D, Murphy L J. Ethnicity, insulin resistance and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care: 2007; 30 286 291 (Pubitemid 46198332)
42. Wu H, Jia W, Bao Y, Lu J, Zhu J, Wang R, Chen Y, Xiang K. Serum retinol binding protein4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract: 2008; 79 185 190
43. Seo J A, Kim N H, Park S Y, Kim H Y, Ryu O H, Lee K W, Lee J, Kim D L, Choi K M, Baik S H, Choi D S, Kim S G. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol: 2008; 68 555 560 (Pubitemid 351388698)
44. Romanowska A, Lebensztejn D M, Skiba E, Tarasw E, Kaczmarski M. Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children preliminary report. Acta Biochim Pol: 2011; 58 35 38
45. Perseghin G, Lattuada G, Cobelli F D, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Maschio A D, Luzi L. Serum retinol binding protein 4, leptin and adiponectin concentrations are related to ectopic fat accumulation. J Clin Endocrin Metab: 2007; 92 4883 4888 (Pubitemid 350223473)
46. Shin M J, Kang S M, Jang Y, Lee J H, Oh J, Chung J H, Chung N. Serum retinol binding protein 4 levels are associated with serum adiponectin levels in non-diabetic, non-obese subjects with hypercholesterolemia. Clin Chim Acta: 2007; 378 227 229 (Pubitemid 46241082)
47. Choi S H, Lee Y J, Park Y J, Kim K W, Lee E J, Lim S, Park do J, Kim S E, Park K S, Jang H C, Cho B Y. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab: 2008; 93 2313 2318 (Pubitemid 351831553)
48. Makino S, Fujiwara M, Suzukawa K, Handa H, Fujie T, Ohtaka Y, Komatsu Y, Aoki Y, Maruyama H, Terada Y, Hashimoto K, Sugimoto T. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Horm Metab Res: 2009; 41 221 226
49. Lim S, Yoon J W, Choi S H, Park Y J, Lee J J, Park J H, Lee S B, Kim K W, Lim J Y, Kim Y B, Park K S, Lee H K, Cho S I, Jang H C. Combined impact of adiponectin and retinol-binding protein 4 on Metabolic Syndrome in elderly people: The Korean Longitudinal Study on Health and Aging. Obesity: 2010; 18 826 832
50. Sasaki M, Otani T, Kawakami M, Ishikawa S. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism: 2010; 59 527 532
51. Rhie Y J, Choi B M, Eun S H, Son C S, Park S H, Lee K H. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J Korean Med Sci: 2011; 26 797 802
52. Usui S, Ichimura M, Ikeda S, Okamoto M. Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women. Clin Chim Acta: 2009; 399 45 48
53. Park S E, Kim D H, Lee J H, Park J S, Kang E S, Ahn C W, Lee H C, Cha B S. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis: 2009; 204 23 25
54. Broch M, Auguet M T, Ramrez R, Olona M, Aguilar C, Megia A, Alcaide M J, Pastor R, Martnez S, Caubet E, Garcia-Espaa A, Richart C. Parallel downregulation of retinol-binding protein-4 and adiponectin expression in subcutaneous adipose tissue of non-morbidly obese subjects. Eur J Endocrinol: 2009; 161 87 94
55. Shim C Y, Park S, Kim J S, Shin D J, Ko Y G, Kang S M, Choi D, Ha J W, Jang Y, Chung N. Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patients. Yonsei Med J: 2010; 51 375 384
56. Lim S, Choi S H, Jeong I K, Kim J H, Moon M K, Park K S, Lee H K, Kim Y B, Jang H C. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. J Clin Endocrinol Metab: 2008; 93 2263 2268 (Pubitemid 351831545)
57. Sell H, Eckel J. Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia: 2007; 50 2221 2223 (Pubitemid 47373848)
58. Guerre-Millo M. Adiponectin: an update. Diabetes Metab: 2008; 34 12 18
59. Volek J S, Phinney S D, Forsythe C E, Quann E E, Wood R J, Puglisi M J, Kraemer W J, Bibus D M, Fernandez M L, Feinman R D. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids: 2009; 44 297 309
60. Zhang W, Della-Fera M A, Hartzell D L, Hausman D, Baile C A. Adipose tissue gene expression profiles in ob/ob mice treated with leptin. Life Sci: 2008; 83 35 42
61. Qi Q, Wang J, Li H, Yu Z, Ye X, Hu F B, Franco O H, Pan A, Liu Y, Lin X. Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. Eur J Endocrinol: 2008; 159 585 593
62. Yildiz B O, Bozdag G, Otegen U, Harmanci A, Boynukalin K, Vural Z, Kirazli S, Yarali H. Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS. Reprod Biomed Online: 2010; 20 150 155
63. Goralski K B, Sinal C J. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Can J Physiol Pharmacol: 2007; 85 113 132 (Pubitemid 46996110)
64. Christou G A, Tellis C C, Elisaf M S, Tselepis A D, Kiortsis D N. The Changes in Plasma Retinol-Binding Protein 4 Levels are Associated With Those of the Apolipoprotein B-Containing Lipoproteins During Dietary and Drug Treatment. Angiology: 2011; May 20 Epub ahead of print
65. Chan D C, Watts G F, Ng T W, Yamashita S, Barrett P H. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Eur J Clin Invest: 2008; 38 743 751
66. Chan D C, Watts G F, Gan S, Wong A T, Ooi E M, Barrett P H. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity. Arterioscler Thromb Vasc Biol: 2010; 30 1043 1050
67. Ng T W, Watts G F, Barrett P H, Rye K A, Chan D C. Effect of weight loss on LDL and HDL kinetics in the Metabolic Syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care: 2007; 30 2945 2950 (Pubitemid 350083149)
68. Reinehr T, Stoffel-Wagner B, Roth C L. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab: 2008; 93 2287 2293 (Pubitemid 351831549)
69. Mitterberger M C, Mattesich M, Klaver E, Lechner S, Engelhardt T, Larcher L, Pierer G, Piza-Katzer H, Zwerschke W. Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction. J Gerontol A Biol Sci Med Sci: 2010; 65 915 923
70. Hermsdorff H H, Zulet M A, Abete I, Martnez J A. Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine: 2009; 36 445 451
71. Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J, Hanacek J, Capel F, Viguerie N, Richterova B, Bajzova M, Hejnova J, Stich V, Langin D. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab: 2007; 92 2330 2335 (Pubitemid 46997142)
72. Kiortsis D N, Tzotzas T, Giral P, Bruckert E, Beucler I, Valsamides S, Turpin G. Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction program. Nutr Metab Cardiovasc Dis: 2001; 11 153 157 (Pubitemid 33686559)
73. Yu Z, Ye X, Wang J, Qi Q, Franco O H, Rennie K L, Pan A, Li H, Liu Y, Hu F B, Lin X. Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older Chinese people. Circulation: 2009; 119 2969 2977
74. Ku Y H, Han K A, Ahn H, Kwon H, Koo B K, Kim H C, Min K W. Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus. J Int Med Res: 2010; 38 782 791
75. Choi K M, Kim T N, Yoo H J, Lee K W, Cho G J, Hwang T G, Baik S H, Choi D S, Kim S M. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrinol (Oxf): 2009; 70 569 574
76. Bradley R L, Jeon J Y, Liu F F, Maratos-Flier E. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab: 2008; 295 E586 E594
77. Ryan A S. Insulin resistance with aging: effects of diet and exercise. Sports Med: 2000; 30 327 346
78. Derosa G, Maffioli P, Ferrari I, DAngelo A, Fogari E, Palumbo I, Randazzo S, Cicero A F. Orlistat and l -carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocr J: 2010; 57 777 786
79. Derosa G, Maffioli P, Salvadeo S A, Ferrari I, Gravina A, Mereu R, D'Angelo A, Palumbo I, Randazzo S, Cicero A F. Sibutramine and l -carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern Med: 2010; 49 1717 1725
80. Mohapatra J, Sharma M, Singh S, Pandya G, Chatterjee A, Balaraman R, Patel P R, Jain M R. Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice. J Pharm Pharmacol: 2009; 61 1493 1498
81. Swarbrick M M, Stanhope K L, Austrheim-Smith I T, Van Loan M D, Ali M R, Wolfe B M, Havel P J. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia: 2008; 51 1901 1911
82. Broch M, Gmez J M, Auguet M T, Vilarrasa N, Pastor R, Elio I, Olona M, Garca-Espaa A, Richart C. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg: 2010; 20 1258 1264
83. Gmez-Ambrosi J, Rodrguez A, Cataln V, Ramrez B, Silva C, Rotellar F, Gil M J, Salvador J, Frhbeck G. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol (Oxf): 2008; 69 208 215 (Pubitemid 352009009)
84. Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Weiss H, Patsch J R, Ebenbichler C F. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity: 2008; 16 2439 2444
85. Lin C C, Lai M M, Li T C, Li C I, Liu C S, Chen C C, Wu M T. Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome. Diabetes Res Clin Pract: 2009; 85 24 29
86. Yoshida A, Matsutani Y, Fukuchi Y, Saito K, Naito M. Analysis of the factors contributing to serum retinol binding protein and transthyreyin levels in Japanese adults. J Atheroscler Thromb: 2006; 13 209 215
87. Mallat Z, Simon T, Benessiano J, Clement K, Taleb S, Wareham N J, Luben R, Khaw K T, Tedgui A, Boekholdt S M. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab: 2009; 94 255 260
88. Von Eyatten M, Lepper P M, Liu D, Lang K, Baumann M, Nawroth P P, Bierhaus A, Dugi K A, Heemann U, Allolio B, Humpert P M. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia: 2007; 50 1930 1937 (Pubitemid 47222861)
89. Schaefer E J, Lamon-Fava S, Ordovas J M, Cohn S D, Schaefer M M, Castelli W P, Wilson P W. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res: 1994; 35 871 882 (Pubitemid 24157238)
90. Friedewald W T, Levy R I, Frederickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem: 1972; 18 499 502
91. National Cholesterol Education Program Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation: 2002; 106 3143 3421
92. Berneis K K, Krauss R M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res: 2002; 43 1363 1379
93. Muggeo M, Zenti M G, Travia D, Sartori A, Trimloni S, Grigolini L, Graziani M S, Cigolini M. Serum retinol levels throughout 2 years of cholesterol-lowering therapy. Metabolism: 1995; 44 398 403
94. Szendroedi J, Anderwald C, Krssak M, Bayerle-Eder M, Esterbauer H, Pfeiler G, Brehm A, Nowotny P, Hofer A, Waldhausl W, Roden M. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care: 2009; 32 209 214
95. Takebayashi K, Suetsugu M, Matsumoto S, Aso Y, Inukai T. Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia. South Med J: 2009; 102 361 368
96. Wu H, Wei L, Bao Y, Lu J, Huamg P, Liu Y, Jia W, Xiang K. Fenofibrate reduces serum retinil-binding protein-4 by suppressing its expression in adipose tissue. Am J Physiol Endocrinol Metab: 2009; 296 628 634
97. Piscator M. Early detection of tubular dysfunction. Kidney Int Suppl: 1991; 34 S15 S17
98. Chan D C, Watts G F, Gan S K, Ooi E M, Barrett P H. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care: 2010; 33 1134 1139
99. Ingelsson E, Lind L. Circulating retinol binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care: 2009; 32 733 735
100. Solini A, Santini E, Madec S, Rossi C, Muscelli E. Retinol-binding protein-4 in women with untreated essential hypertension. Am J Hypertens: 2009; 22 1001 1006
101. Bobbert T, Raila J, Schwarz F, Mai K, Henze A, Pfeiffer A F, Schweigert F J, Spranger J. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis: 2010; 213 549 551
102. Christensen E I, Moskaug J O, Vorum H, Jacobsen C, Gundersen T E, Nykjaer A, Blomhoff R, Willnow T E, Moestrup S K. Evidence for an essential role of megalin in transepithelial transport of retinol. J Am Soc Nephrol: 1999; 10 685 695 (Pubitemid 29149517)
103. Raila J, Willnow T E, Schweigert F J. Megalin-mediated reuptake of retinol in the kidneys of mice is essential for vitamin A homeostasis. J Nutr: 2005; 135 2512 2516 (Pubitemid 43156588)
104. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Blher M, Stumvoll M, Fasshauer M. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care: 2007; 30 2588 2592 (Pubitemid 47547801)
105. Chang Y H, Lin K D, Wang C L, Hsieh M C, Hsiao P J, Shin S J. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients. Diabetes Metab Res Rev: 2008; 24 629 634
106. Graham T E, Wason C J, Blher M, Kahn B B. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia: 2007; 50 814 823 (Pubitemid 46355817)
107. Promintzer M, Krebs M, Todoric J, Luger A, Bischof M G, Nowotny P, Wagner O, Esterbauer H, Anderwald C. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab: 2007; 92 4306 4312 (Pubitemid 350074749)
108. Gavi S, Qurashi S, Stuart L M, Lau R, Melendez M M, Mynarcik D C, McNurlan M A, Gelato M C. Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity (Silver Spring): 2008; 16 893 895 (Pubitemid 351465649)